XY Capital’s Johnson & Johnson JNJ Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
Sell
-3,900
Closed -$807K 199
2025
Q4
$807K Buy
3,900
+200
+5% +$39.5K 0.51% 39
2025
Q3
$686K Buy
+3,700
New +$634K 0.36% 70
2025
Q2
Sell
-2,400
Closed -$398K 120
2025
Q1
$398K Sell
2,400
-1,200
-33% -$188K 0.11% 134
2024
Q4
$521K Buy
+3,600
New +$558K 0.25% 99
2024
Q3
Sell
-11,700
Closed -$1.71M 106
2024
Q2
$1.71M Buy
11,700
+6,700
+134% +$996K 1.08% 25
2024
Q1
$791K Sell
5,000
-2,500
-33% -$398K 0.35% 63
2023
Q4
$1.18M Sell
7,500
-3,600
-32% -$552K 0.69% 38
2023
Q3
$1.73M Buy
+11,100
New +$1.83M 0.99% 25

Other funds holding JNJ

XY Capital's JNJ Position: Q1 2026 in Review

XY Capital sold out of Johnson & Johnson (JNJ) in Q1 2026, closing a stake of 798 shares — an estimated $165K sold.

XY Capital first reported a position in JNJ in Q3 2023 and held it in 4 quarters. The position peaked at $927K in Q3 2023. 4,617 funds tracked by Wall St. Rank hold JNJ as of Q1 2026.

  • XY Capital reported no remaining Johnson & Johnson position as of Q1 2026 after selling out during the quarter.
  • XY Capital sold 798 Johnson & Johnson shares in Q1 2026, an estimated $165K.
  • XY Capital first reported a position in Johnson & Johnson in Q3 2023 and held it in 4 quarters.
  • XY Capital's Johnson & Johnson position peaked at $927K in Q3 2023.
  • 4,617 funds tracked by Wall St. Rank held Johnson & Johnson as of Q1 2026.

Based on XY Capital's 13F filing for Q1 2026, filed 12 May 2026.